Daily Broadcaster

Histobiolab Provides Efficient IHC Staining Based on Immunohistochemistry for Project Planning and Development

 Breaking News
  • No posts were found

Histobiolab Provides Efficient IHC Staining Based on Immunohistochemistry for Project Planning and Development

January 24
13:06 2022
Histobiolab announced the release of its efficient IHC staining based on immunohistochemistry for project planning and development.

New York, USA – January 24, 2022 – Histobiolab, the branch of Creative Bioarray, is a full-service provider that can satisfy histology and histopathology needs. With the comprehensive histopathology platform and computational pathology team, Histobiolab is capable to offer a broad range of tissue processing, immunohistochemistry (IHC) and in situ hybridization services, molecular and digital pathology to deliver consistent, high quality and reproducible results. Recently, Histobiolab announced the release of its efficient IHC staining based on immunohistochemistry for project planning and development.

The basic principles of immunology determine that the binding of antigens to antibodies is highly specific, and cross-reaction occurs only when cross-antigens are present in tissue cells. Antibodies can still bind to antigens in tissue cells after being diluted thousands of times, tens of thousands of times, or even hundreds of millions of times, making immunohistochemical methods more and more convenient for routine pathological diagnosis. Immunohistochemistry service can accurately locate antigens in tissues and cells through antigen-antibody reaction and color reaction so that different antigens can be located and observed in the same tissue or cell at the same time.

Histobiolab performs IHC, IF, and ICC staining of formalin-fixed, paraffin-embedded tissue sections, fresh frozen sections, cultured cells, and whole-mount samples using well-established, optimized antibody staining protocols and dual-label IHC services to localize both proteins simultaneously on the same tissue section. In order to perform routine IHC/IF staining successfully and consistently, it is critical to developing an optimal protocol for a specific antibody. Histobiolab’s IHC/IF validation services have established protocols for more than 200 biomarkers, covering oncology, immunology, neuroscience and metabolic diseases.

Besides, Histobiolab offers multiplex IHC and IF assays to detect multiple targets on a single slice. The automated approach can provide customers with consistent, reproducible, and high-throughput service that can be adapted for a variety of protocols and detection strategies.

“We can provide you with fast, accurate and convenient service. Our pathology laboratory uses the latest technologies, methods and equipment to meet all your needs.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “Our experienced team of professionals can meet customer needs in sectioning, embedding, staining, IHC and IF, imaging and analysis.”

About Histobiolab

As a mature division of Creative Bioarray, Histobiolab definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, we are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerate drug development and improve research quality for worldwide projects.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States
Website: https://histobiolab.com